中文版 | English
题名

Synthetic Biohybrids of Red Blood Cells and Cascaded-Enzymes@ Metal-Organic Frameworks for Hyperuricemia Treatment

作者
通讯作者Wuttke, Stefan; Liu, Kaisheng; Zhu, Wei
发表日期
2023-12-01
DOI
发表期刊
EISSN
2198-3844
卷号11期号:5
摘要
["Hyperuricemia, caused by an imbalance between the rates of production and excretion of uric acid (UA), may greatly increase the mortality rates in patients with cardiovascular and cerebrovascular diseases. Herein, for fast-acting and long-lasting hyperuricemia treatment, armored red blood cell (RBC) biohybrids, integrated RBCs with proximal, cascaded-enzymes of urate oxidase (UOX) and catalase (CAT) encapsulated within ZIF-8 framework-based nanoparticles, have been fabricated based on a super-assembly approach. Each component is crucial for hyperuricemia treatment: 1) RBCs significantly increase the circulation time of nanoparticles; 2) ZIF-8 nanoparticles-based superstructure greatly enhances RBCs resistance against external stressors while preserving native RBC properties (such as oxygen carrying capability); 3) the ZIF-8 scaffold protects the encapsulated enzymes from enzymatic degradation; 4) no physical barrier exists for urate diffusion, and thus allow fast degradation of UA in blood and neutralizes the toxic by-product H2O2. In vivo results demonstrate that the biohybrids can effectively normalize the UA level of an acute hyperuricemia mouse model within 2 h and possess a longer elimination half-life (49.7 +/- 4.9 h). They anticipate that their simple and general method that combines functional nanomaterials with living cell carriers will be a starting point for the development of innovative drug delivery systems.","Armored red blood cell (RBC) biohybrids, integrated RBCs with proximal, cascaded-enzymes of urate oxidase and catalase encapsulated within ZIF-8 framework-based nanoparticles, have been fabricated for fast-acting and long-lasting urate-lowering therapy. RBC biohybrids could normalize the UA level of acute hyperuricemia model mice within 2 h, and possessed an elimination half-life of 49.7 +/- 4.9 h, which is over thrice longer than that of free UOX, representing an innovative drug carrier for hyperuricemia treatment.image"]
关键词
相关链接[来源记录]
收录类别
SCI ; EI
语种
英语
学校署名
通讯
资助项目
National Natural Science Foundation of China["22372061","21972047"] ; Natural Science Foundation of Guangdong Province, China["2021A1515010724","2021A1515220051","2022A0505050008"] ; Guangdong Provincial Pearl River Talents Program[2019QN01Y314] ; Program for Guangdong Introducing Innovative and Entrepreneurial Teams[2019ZT08Y318] ; Science and Technology Project of Guangzhou, China["202102020352","202102020259"]
WOS研究方向
Chemistry ; Science & Technology - Other Topics ; Materials Science
WOS类目
Chemistry, Multidisciplinary ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary
WOS记录号
WOS:001113504900001
出版者
Scopus记录号
2-s2.0-85178434152
来源库
Web of Science
引用统计
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/638908
专题南方科技大学第一附属医院
作者单位
1.South China Univ Technol, Sch Biol & Biol Engn, MOE Int Joint Res Lab Synthet Biol & Med, Guangzhou 510006, Peoples R China
2.Southern Med Univ, Guangdong Acad Med Sci, Med Res Inst, Guangdong Prov Peoples Hosp, Guangzhou 510080, Peoples R China
3.UPV EHU Sci Pk, Basque Ctr Mat, BCMaterials, Leioa 48940, Spain
4.IKERBASQUE, Basque Fdn Sci, Bilbao 48009, Spain
5.China Natl Tobacco Corp, 55 South Yuetan Blvd, Beijing 100045, Peoples R China
6.Beijing Univ Chem Technol, Coll Mat Sci & Engn, Beijing 100029, Peoples R China
7.Guangzhou Med Univ, Affiliated Hosp 2, State Key Lab Resp Dis, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 510260, Peoples R China
8.Univ New Mexico, Ctr Microengn Mat, Albuquerque, NM 87131 USA
9.Univ New Mexico, Dept Chem & Biol Engn, Albuquerque, NM 87131 USA
10.Jinan Univ, Shenzhen Peoples Hosp, Guangdong Prov Clin Res Ctr Geriatr, Clin Med Coll 2,Shenzhen Clin Res Ctr Geriatr, Shenzhen 518020, Peoples R China
11.Southern Univ Sci & Technol, Affiliated Hosp 1, Shenzhen 518020, Peoples R China
通讯作者单位南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Li, Zeyu,Xue, Liecong,Yang, Junxian,et al. Synthetic Biohybrids of Red Blood Cells and Cascaded-Enzymes@ Metal-Organic Frameworks for Hyperuricemia Treatment[J]. ADVANCED SCIENCE,2023,11(5).
APA
Li, Zeyu.,Xue, Liecong.,Yang, Junxian.,Wuttke, Stefan.,He, Peiying.,...&Zhu, Wei.(2023).Synthetic Biohybrids of Red Blood Cells and Cascaded-Enzymes@ Metal-Organic Frameworks for Hyperuricemia Treatment.ADVANCED SCIENCE,11(5).
MLA
Li, Zeyu,et al."Synthetic Biohybrids of Red Blood Cells and Cascaded-Enzymes@ Metal-Organic Frameworks for Hyperuricemia Treatment".ADVANCED SCIENCE 11.5(2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Li, Zeyu]的文章
[Xue, Liecong]的文章
[Yang, Junxian]的文章
百度学术
百度学术中相似的文章
[Li, Zeyu]的文章
[Xue, Liecong]的文章
[Yang, Junxian]的文章
必应学术
必应学术中相似的文章
[Li, Zeyu]的文章
[Xue, Liecong]的文章
[Yang, Junxian]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。